Prognostic factors and early risk-adapted therapy in patients with chronic lymphocytic leukemia in Binet stage A Not provided at time of registration

• Country Germany
• organs None
• Specialty None

Phase III trial of combined immunochemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FC-R) versus chemotherapy with Fludarabine and Cyclophosphamide (FC) alone in patients with previously untreated chronic lymphocytic leukaemia Not provided at time of registration

• Country Germany
• organs None
• Specialty None